SCHEMBL2717259

SCHEMBL2717259

C=C(C#N)C(=O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 7/20 0.54
▸ CES1 P23141 6/20 0.54
▸ ALDH1A1 P00352 6/20 0.50
▸ MAPT P10636 5/20 0.50
▸ LMNA P02545 4/20 0.50
▸ NPSR1 Q6W5P4 4/20 0.50
▸ MAPK1 P28482 3/20 0.50
▸ XBP1 P17861 2/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ ATM Q13315 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ KMT2A Q03164 3/20 0.47
▸ USP2 O75604 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.45
▸ PKM P14618 1/20 0.45
▸ EGFR P00533 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL8356613 0.79 TSHR (0.56) CES2CES1ALDH1A1MAPTLMNA
Benzophenone SCHEMBL2536126 0.79 ALDH1A1 (0.56) ALDH1A1MAPTLMNANPSR1MAPK1
SCHEMBL8937850 0.79 CA12 (0.50) CES2CES1ALDH1A1MAPTLMNA
SCHEMBL27489283 0.77 ALDH1A1 (0.39) CES2CES1ALDH1A1MAPTLMNA
SCHEMBL25219103 0.77 CES2 (0.59) CES2CES1ALDH1A1MAPTLMNA
Benzil SCHEMBL27539146 0.75 CES2 (0.93) CES2CES1ALDH1A1MAPTLMNA
Benzil SCHEMBL6031169 0.75 CES2 (0.93) CES2CES1ALDH1A1MAPTLMNA
Benzil SCHEMBL7571874 0.75 CES2 (0.93) CES2CES1ALDH1A1MAPTLMNA
Benzil SCHEMBL27974030 0.75 CES2 (0.70) CES2CES1ALDH1A1MAPTLMNA
Naphthalene SCHEMBL27595244 0.74 CYP1A2 (0.41) CES2CES1ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2439803-B1 PHOTOELECTRIC CONVERSION ELEMENT AND METHOD FOR PRODUCING SAME, PHOTOSENSOR, IMAGING ELEMENT AND METHOD OF DRIVING SAME FUJIFILM CORP (JP) 2017-11-08 — — EP disclosed
US-9349965-B2 Photoelectric conversion material, film containing the material, photoelectric conversion device, method for preparing photoelectric conversion device, method for using photoelectric conversion device, photosensor and imaging device FUJIFILM CORPORATION (JP) 2016-05-24 — — US disclosed
US-9035055-B2 Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods FUJIFILM CORPORATION (JP) 2015-05-19 — — US disclosed
US-20150129861-A1 ORGANIC MATERIAL FOR DEPOSITION, AND ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, DEPOSITION METHOD, AND MANUFACTURING METHOD FOR ORGANIC PHOTOELECTRONIC ONVERSION ELEMENT OBTAINED USING THE SAME FUJIFILM CORPORATION (JP) 2015-05-14 — — US disclosed
US-9012762-B2 Photoelectric conversion element and imaging device FUJIFILM CORPORATION (JP) 2015-04-21 — — US disclosed
US-20140374733-A1 PHOTOELECTRIC CONVERSION ELEMENT, METHOD FOR USING THE SAME, IMAGING DEVICE, PHOTOSENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2014-12-25 — — US disclosed
EP-2403027-B1 Photoelectric conversion device and imaging device FUJIFILM CORP (JP) 2014-11-05 — — EP disclosed
EP-2786983-A1 Compounds for use in a photoelectric conversion material, and intermediates for the preparation thereof Fujifilm Corporation (JP) 2014-10-08 — — EP disclosed
US-8847208-B2 Photoelectric conversion device and imaging device having decreased dark current FUJIFILM CORPORATION (JP) 2014-09-30 — — US disclosed
US-8847141-B2 Photoelectric conversion element, production method thereof, photosensor, imaging device and their driving method FUJIFILM CORPORATION (JP) 2014-09-30 — — US disclosed
US-20100308311-A1 PHOTOELECTRIC CONVERSION DEVICE AND IMAGING DEVICE FUJIFILM CORPORATION (JP) 2010-12-09 — — US disclosed
US-20100308372-A1 PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF AND IMAGING DEVICE FUJIFILM CORPORATION (JP) 2010-12-09 — — US disclosed
EP-2259359-A2 Photoelectric conversion device, production method thereof and imaging device Fujifilm Corporation (JP) 2010-12-08 — — EP disclosed
EP-2259358-A2 Photoelectric conversion device and imaging device Fujifilm Corporation (JP) 2010-12-08 — — EP disclosed
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME FUJIFILM CORPORATION (JP) 2010-08-19 — — US disclosed
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME FUJIFILM CORPORATION (JP) 2010-08-19 — — US disclosed
US-20100130638-A1 ULTRAVIOLET ABSORBENT COMPOSITION FUJIFILM CORPORATION (JP) 2010-05-27 — — US disclosed
US-20100025642-A1 ULTRAVIOLET ABSORBENT COMPOSITION FUJIFILM CORPORATION (JP) 2010-02-04 — — US disclosed
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-09-24 — — US disclosed
US-20090223566-A1 PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING DEVICE FUJIFILM CORPORATION (JP) 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME F12, F2, CYP24A1 CES2 3734/4885CES1 3440/4885ALDH1A1 1492/4885
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND SQOR, NQO1, PBRM1 CES2 963/4885CES1 1080/4885ALDH1A1 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback